Dissociation between systemic and pulmonary anti‐inflammatory effects of dexamethasone in humans

Aims The local pulmonary inflammatory response has a different temporal and qualitative profile compared with the systemic inflammatory response. Although glucocorticoids substantially downregulate the systemic release of acute‐phase mediators, it is not clear whether they have comparable inhibitory effects in the human lung compartment. Therefore, we compared the anti‐inflammatory effects of a pure glucocorticoid agonist, dexamethasone, on bronchoalveolar lavage and blood cytokine concentrations in response to bronchially instilled endotoxin. Methods In this randomized, double‐blind and placebo‐controlled trial, 24 volunteers received dexamethasone or placebo and had endotoxin instilled into a lung segment and saline instilled into a contralateral segment, followed by bronchoalveolar lavage. Results Bronchially instilled endotoxin induced a local and systemic inflammatory response. Dexamethasone strongly blunted the systemic interleukin (IL) 6 and C‐reactive protein release. In sharp contrast, dexamethasone left the local release of acute‐phase mediators in the lungs virtually unchanged: bronchoalveolar lavage levels of IL‐6 were only 18% lower and levels of IL‐8 were even higher with dexamethasone compared with placebo, although the differences between treatments were not statistically significant (P = 0.07 and P = 0.08, respectively). However, dexamethasone had inhibitory effects on pulmonary protein extravasation and neutrophil migration. Conclusions The present study demonstrated a remarkable dissociation between the systemic anti‐inflammatory effects of glucocorticoids and its protective effects on capillary leak on the one hand and surprisingly low anti‐inflammatory effects in the lungs on the other.

[1]  Dave Singh,et al.  Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects , 2015, European Journal of Clinical Pharmacology.

[2]  P. Pelosi,et al.  The Effects of Dasatinib in Experimental Acute Respiratory Distress Syndrome Depend on Dose and Etiology , 2015, Cellular Physiology and Biochemistry.

[3]  Dave Singh,et al.  Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease. , 2015, British journal of clinical pharmacology.

[4]  Fengli Xu,et al.  Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury , 2015, Respiratory Research.

[5]  L. Konge,et al.  Transcompartmental Inflammatory Responses in Humans: IV Versus Endobronchial Administration of Endotoxin* , 2014, Critical care medicine.

[6]  B. Li,et al.  Maresin 1 mitigates LPS‐induced acute lung injury in mice , 2014, British journal of pharmacology.

[7]  D. Jayne,et al.  SUMMARY OF PRODUCT CHARACTERISTICS , 2014 .

[8]  A. Yokoyama,et al.  A novel lung injury animal model using KL-6-measurable human MUC1-expressing mice. , 2013, Biochemical and biophysical research communications.

[9]  Dave Singh,et al.  Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects. , 2012, British journal of clinical pharmacology.

[10]  S. Farrow,et al.  IFN‐γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid‐resistant STAT1 activation , 2012, British journal of pharmacology.

[11]  I. Heimbeck,et al.  Differential Inflammatory Response to Inhaled Lipopolysaccharide Targeted Either to the Airways or the Alveoli in Man , 2012, PloS one.

[12]  Honghui Wang,et al.  Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome* , 2012, Critical care medicine.

[13]  K. Ueno,et al.  1α,25-Dihydroxyvitamin D3 inhibits neutrophil recruitment in hamster model of acute lung injury , 2011, Steroids.

[14]  A. Gounni,et al.  The Molecular Mechanisms of Glucocorticoids-Mediated Neutrophil Survival , 2011, Current drug targets.

[15]  M. Bauer,et al.  Bbeta(15-42) protects against acid-induced acute lung injury and secondary pseudomonas pneumonia in vivo. , 2009, American journal of respiratory and critical care medicine.

[16]  J. Armstrong,et al.  Glucocorticoid sensitivity of lipopolysaccharide‐stimulated chronic obstructive pulmonary disease alveolar macrophages , 2009, Clinical and experimental immunology.

[17]  D. Sin,et al.  Endotoxin-induced translocation of interleukin-6 from lungs to the systemic circulation , 2009, Innate immunity.

[18]  L. Edwards,et al.  Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD , 2009, European Respiratory Journal.

[19]  T. van der Poll,et al.  Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans. , 2008, American journal of respiratory and critical care medicine.

[20]  M. Eisenhut.  Acute lower respiratory tract infection. , 2008, The New England journal of medicine.

[21]  J. Leitner,et al.  Duffy antigen modifies the chemokine response in human endotoxemia , 2008, Critical care medicine.

[22]  G. Meduri,et al.  Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. , 2007, Chest.

[23]  T. van der Poll,et al.  Prednisolone Dose-Dependently Influences Inflammation and Coagulation during Human Endotoxemia1 , 2007, The Journal of Immunology.

[24]  J. Leitner,et al.  Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia , 2006, Clinical pharmacology and therapeutics.

[25]  L. Ware.  Prognostic determinants of acute respiratory distress syndrome in adults: Impact on clinical trial design , 2005, Critical care medicine.

[26]  Jerry A Nick,et al.  Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. , 2004, Blood.

[27]  B. Jilma,et al.  Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia , 2004, Critical care medicine.

[28]  D. Górecka,et al.  Inhibitory capacity of different steroids on neutrophil migration across a bilayer of endothelial and bronchial epithelial cells. , 2003, European journal of pharmacology.

[29]  S. Banks,et al.  Local inflammatory responses following bronchial endotoxin instillation in humans. , 2001, American journal of respiratory and critical care medicine.

[30]  B. Vargaftig,et al.  Airway administration of Escherichia coli endotoxin to mice induces glucocorticosteroid-resistant bronchoconstriction and vasopermeation. , 2001, American journal of respiratory cell and molecular biology.

[31]  C. Kirschbaum,et al.  Tissue specificity of glucocorticoid sensitivity in healthy adults. , 2000, The Journal of clinical endocrinology and metabolism.

[32]  U. Holmskov,et al.  Localization of Lung Surfactant Protein D on Mucosal Surfaces in Human Tissues1 , 2000, The Journal of Immunology.

[33]  A. Torres,et al.  Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study. , 1999, The European respiratory journal.

[34]  H. Eichler,et al.  Effects of Endotoxemia on Thrombopoiesis in Men , 1999, Thrombosis and Haemostasis.

[35]  K. Chung,et al.  Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects , 1998, Thorax.

[36]  H. Eichler,et al.  Dexamethasone down‐regulates the expression of L‐selectin on the surface of neutrophils and lymphocytes in humans* , 1997, Clinical pharmacology and therapeutics.

[37]  S. Zuckerman,et al.  Glucocorticoid effects in an endotoxin-induced rat pulmonary inflammation model: differential effects on neutrophil influx, integrin expression, and inflammatory mediators. , 1996, American journal of respiratory cell and molecular biology.

[38]  D. Remick,et al.  The intratracheal administration of endotoxin: X. Dexamethasone downregulates neutrophil emigration and cytokine expression in vivo , 1996, Inflammation.

[39]  B. Crestani,et al.  Compartmentalized cytokine production within the human lung in unilateral pneumonia. , 1994, American journal of respiratory and critical care medicine.

[40]  G. D. Martich,et al.  Compartmentalization of the acute cytokine response in humans after intravenous endotoxin administration. , 1993, Journal of applied physiology.

[41]  R. Rylander,et al.  Lipopolysaccharide (LPS) inhalation in healthy subjects increases neutrophils, lymphocytes and fibronectin levels in bronchoalveolar lavage fluid. , 1992, The European respiratory journal.

[42]  J. Elias,et al.  Human alveolar macrophage and blood monocyte interleukin-6 production. , 1990, American journal of respiratory cell and molecular biology.

[43]  C. Sprung,et al.  High-dose corticosteroids in patients with the adult respiratory distress syndrome. , 1987, The New England journal of medicine.

[44]  D. Ray,et al.  Reduced glucocorticoid receptor expression and function in airway neutrophils. , 2012, International immunopharmacology.

[45]  M. Madani,et al.  Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy. , 2012, Chest.

[46]  P. Lindenauer,et al.  CARING FOR THE CRITICALLY ILL PATIENT Association of Corticosteroid Dose and Route of Administration With Risk of Treatment Failure in Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 2010 .

[47]  M. Dentener,et al.  Evaluation of oral corticosteroids and phosphodiesterase-4 inhibitor on the acute inflammation induced by inhaled lipopolysaccharide in human. , 2007, Pulmonary pharmacology & therapeutics.

[48]  T. Standiford,et al.  Regulation of human alveolar macrophage- and blood monocyte-derived interleukin-8 by prostaglandin E2 and dexamethasone. , 1992, American journal of respiratory cell and molecular biology.

[49]  T. Standiford,et al.  Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta. , 1990, American journal of respiratory cell and molecular biology.

[50]  N. Olson,et al.  Dexamethasone and indomethacin modify endotoxin-induced respiratory failure in pigs. , 1985, Journal of applied physiology.